References
- Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213–26.
- Donnenberg AD, Koch EK, Griffin DL, Stanczak HM, Kiss JE, Carlos TM, . Viability of cryopreserved BM progenitor cells stored for more than a decade. Cytotherapy. 2002;4:157–63.
- Berenson R, Bensinger W, Hill R, Andrews R, Garcia-Lopez J, Kalamasz D, . Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood. 1991;77:1717–22.
- Shpall E, Jones R, Bearman S, Franklin W, Archer P, Curiel T, . Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol. 1994;12:28–36.
- Gorin N, Lopez M, Laporte J, Quittet P, Lesage S, Lemoine F, . Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood. 1995;85:1647–54.
- McKenna DH, Adams S, Sumstad D, Sumstad T, Kadidlo D, Gee AP, . CD34 cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine. Cytotherapy. 2010;12:170–7.
- Wagner JE, Santos GW, Noga SJ, Rowley SD, Davis J, Vogelsang GB, . Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I–II clinical trial. Blood. 1990;75:1370–7.
- Spitzer TR, Davis JM. Buffy coat preparation using the haemonetics model 30. Areman EM, Deeg HJ, Sacher RA. Bone Marrow and Stem Cell Processing: A Manual of Current Techniques. Philadelphia: FA Davis; 1992. 113–7.
- Spitzer TR, Donnelly SF. Red blood cell sedimentation. Areman EM, Deeg HJ, Sacher RA. Bone Marrow and Stem Cell Processing: A Manual of Current Techniques. Philadelphia: FA Davis; 1992. 126–9.
- Warkentin PI, Hilden JM, Kersey JH, Ramsay NK, McCullough J. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Vox Sang. 1985;48:89–104.
- Donnenberg AD. T-cell depletion and allograft engineering. Ball ED, Lister J, Law P. Hematopoietic Stem Cell Therapy. Philadelphia: Churchill Livingstone; 2000. 335–44.
- Donnenberg VS, Donnenberg AD, Zimmerlin L, Landreneau RJ, Bhargava R, Wetzel RA, . Localization of CD44 and CD90 positive cells to the invasive front of breast tumors. Clin Cytom. 2010;78B(5)287–301.
- Pierelli L, Bonanno G, Rutella S, Marone M, Scambia G, Leone G. CD105 (Endoglin) expression on hematopoietic stem/progenitor cells. Leuk Lymph. 2001;42:1195–206.
- Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, . Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation. 2007;115:3165–72.
- Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M, . CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation. 2006;114:2163–9.